4572 — Carna Biosciences Balance Sheet
0.000.00%
Last trade - 00:00- ¥4bn
- ¥3bn
- ¥636m
Annual balance sheet for Carna Biosciences, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 4,299 | 3,818 | 3,379 | 2,889 | 2,108 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 129 | 1,244 | 182 | 788 | 87.1 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4,708 | 5,318 | 4,104 | 4,191 | 2,738 |
| Net Property, Plant And Equipment | 53.3 | 51.6 | 100 | 105 | 0 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 4,835 | 5,433 | 4,266 | 4,350 | 2,772 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 727 | 775 | 436 | 376 | 223 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,011 | 1,117 | 625 | 472 | 297 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 3,824 | 4,316 | 3,642 | 3,878 | 2,475 |
| Total Liabilities & Shareholders' Equity | 4,835 | 5,433 | 4,266 | 4,350 | 2,772 |
| Total Common Shares Outstanding |